Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Canada Finalizes Patent Term Adjustment Rules

    On January 1, 2025, Canada will implement a patent term adjustment (PTA) system to account for unreasonable delays by the Canadian Intellectual Property Office (CIPO) in issuing a patent.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canada To Consider Gene Patent Eligibility: Looking Abroad For Insight

    Melanie Szweras and Teresa MacLean write for Biotechnology Focus Magazine discussing how gene patent elgibility in Canada may soon be evaluated in light of a challenge brought by the Children's Hospital of Eastern Ontario.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canadian Chapter Of Financier Worldwide Patent & Trademarks Annual Review 2016

    There seems to be an increasing reluctance to spend money on securing and enforcing patents and trademarks.
    CanadaIntellectual Property
    McMillan LLP
    McMillan LLP
  • Article

    Canadian Intellectual Property Office Experiencing Backlog-Related Delays Following Recent Public Servant Strike

    The Canadian Intellectual Property Office (CIPO) experienced delays in the following areas during last month's Public Service Alliance of Canada strike...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Canadian Intellectual Property Office To Increase Fees On January 1, 2024

    The Canadian Intellectual Property Office (CIPO) Canada is introducing significant government fee increases (in most cases by approximately 25%, with some exceptions) on January 1, 2024.
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    Canadian Patents, Trademarks, And Industrial Designs: Final Extension Of Deadlines In Response To The COVID-19 Pandemic

    In response to the COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has extended many (but not all) patent, trademark, and industrial design deadlines that ordinarily fall...
    CanadaIntellectual Property
    Bennett Jones LLP
    Bennett Jones LLP
  • Article

    Canadian Update On International IP Treaties

    Earlier this week, the government introduced an unprecedented five international intellectual property treaties in the House of Commons on the same day.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    CIPO Fast Tracks Critical Minerals Patents

    Canada's Intellectual Property Office has introduced a new expedited examination program for patent applications in critical technology sectors. The Key Technology Expedited Program waives the advanced examination fee and promises first office action within seven months for qualifying applications related to critical minerals supply chain innovations.
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    CIPO Releases New Practice Notice On Patentable Subject Matter In Computer Implemented Inventions And Methods Of Medical Diagnostics

    The Canadian Intellectual Property Office (CIPO) has released a new practice notice providing guidance on CIPO's approach...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    CIPO Updates Industrial Design Office Practice Manual – What Applicants Should Know

    Those who have applied for, or are looking to apply for, industrial design protection in Canada should be aware that the Canadian Intellectual Property Office (CIPO)...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Concerned About Patent Deadlines During the COVID-19 Pandemic? The Canadian Intellectual Property Office Offers An FAQ Page

    The rapidly evolving coronavirus pandemic continues to have a significant impact on intellectual property rights holders in Canada and around the world.
    CanadaIntellectual Property
    Fasken
    Fasken
  • Article

    Consultations On Proposed Fee Increases (CIPO)

    The Canadian Intellectual Property Office ("CIPO") is running consultations regarding an increase in government fees. The proposed fee structure and other regulatory changes...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Court Permits Addition Of Inventor To A Patent That Is Subject Of Ongoing Litigation

    In Regeneron Pharmaceuticals, Inc v Canada (AG), 2023 FC 768, the Federal Court granted Regeneron's application to add an inventor to its issued patent, which was the subject of pending...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    COVID-19 Impact: Canadian Intellectual Property Office Extends All Deadlines To May 1, 2020

    As expected, as part of its ongoing efforts to manage the impact of the COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO)...
    CanadaIntellectual Property
    Cassels
    Cassels
  • Article

    COVID-19 Impact: Further Extension Of Intellectual Property Timelines

    As governments continue to grapple with the lingering impact of the COVID-19 pandemic, on May 13, 2020, the Canadian Intellectual Property Office (CIPO)...
    CanadaIntellectual Property
    Cassels
    Cassels
  • Article

    COVID-19 Update: Canadian Intellectual Property Office Deadlines Extended Until July 6, 2020

    In view of the ongoing COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Dabus Saga Continues: Loss For Dr. Stephen Thaler In New Zealand Appeal

    DABUS, short for Device for the Autonomous Bootstrapping of Unified Sentience, has suffered another court loss in it's creator's quest for it to be recognized as an inventor...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Diagnostic Test Kit: Integration Of Patented Technologies

    Since the beginning of the pandemic, the Food and Drug Administration (FDA) has been at a rapid pace in evaluating COVID-19 related diagnostic tests, amongst which include those that utilize patented technologies.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Divided Success In Sandoz's Motion To Strike Monetary Remedies And Other Novel Claims In Rituximab PMNOC Actions

    A Federal Court Order has issued on a motion to strike brought by Sandoz in four actions relating to infringement of rituximab patents.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Emergency Legislation To Allow Compulsory Licensing To Deal With COVID-19

    On 25 March 2020, Bill C-13 An Act respecting certain measures in response to COVID-19 received Royal Assent. This emergency legislation amends the Patent Act to authorize the...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Showing 181–200 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics